Oscar Health (OSCR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual meeting scheduled for June 4, 2026, to be held virtually, with voting available online, by phone, or mail.
Key business includes election of eight directors, advisory vote on executive compensation, and ratification of PWC as auditor.
Company highlights include record membership growth to 3.4 million, 28% revenue increase to $11.7B, and significant SG&A ratio improvement.
Strategic leadership changes and compensation program updates reflect a focus on long-term growth and shareholder alignment.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of eight directors, (2) advisory say-on-pay for executive compensation, (3) ratification of PWC as independent auditor.
Board recommends voting FOR all proposals.
Shareholders may submit additional proposals for future meetings per bylaw requirements.
Board of directors and corporate governance
Board consists of eight nominees with diverse backgrounds in healthcare, technology, finance, and public policy.
Majority of directors and all committees are independent; Mr. Sankaran to become independent Chair after the meeting.
Active board refreshment with three new directors in five years; robust annual board and committee evaluations.
Stockholder engagement led to changes in committee composition and incentive metrics.
Comprehensive director orientation and ongoing education programs in place.
Latest events from Oscar Health
- AI, transparency, and financial incentives are reshaping consumer-driven healthcare strategies.OSCR
7th Annual Healthcare Symposium9 Jul 2026 - Q1 2025 revenue up 42%, net income up 55%, and membership exceeded 2 million.OSCR
Q1 20259 Jul 2026 - 2025 revenue up 28% with record membership; 2026 targets profitability and margin gains.OSCR
Q4 20258 Jul 2026 - Three-year plan targets 20% revenue CAGR, 5% margin, and ICHRA-driven growth, powered by technology.OSCR
Investor Day 20248 Jul 2026 - Strong 2026 performance, favorable trends, and AI-driven integrity shape a stable outlook.OSCR
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Board transitions, robust growth, and all proposals approved; no Q&A from shareholders.OSCR
AGM 20264 Jun 2026 - Revenue and net income soared, membership surged, but regulatory risks persist.OSCR
Q1 20267 May 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the June 2026 meeting.OSCR
Proxy filing23 Apr 2026 - Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026